Skip to main content
. 2019 Nov 1;22(5):675–683. doi: 10.1093/neuonc/noz208

Fig. 4.

Fig. 4

Proposed methods of quantification of burden of disease in patients with LM. Radiographic assessment, CTC quantification, and cfDNA concentration can be used as quantitative measures of disease burden at the time of LM diagnosis. Increasing burden of disease (more radiographic sites of disease, elevated CTCs, and higher CSF cfDNA concentration) are associated with shorter survival times in patients with LC-LM.